Context Therapeutics Inc. Share Price
NASDAQ: CNTX$0.00
+0.00 (0.00%) Context Therapeutics Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Context Therapeutics Inc. Share Price Chart
$0.00$0.00
L
H
Context Therapeutics Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-0.38 | Revenue (TTM) N/A | Return On Equity (TTM) -59.73% |
Profit Margin N/A | Debt to Equity 0.13 | Quarterly Earnings Growth YoY 44.48% |
Context Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Context Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Context Therapeutics Inc.
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Context Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
CNTX Share Price FAQs
What is Context Therapeutics Inc. share price today?
Context Therapeutics Inc. share price today is $0.00 as on August 9, 2026 at 10:17 pm IST.
What is the 52 week high and 52 week low of Context Therapeutics Inc. stock?
52 week high/low data for Context Therapeutics Inc. is currently unavailable.
What is CNTX's net income for the last quarter?
CNTX's net income for the last quarter is -0.01B USD.
Can I buy CNTX shares in India?
Yes. You can buy CNTX in India by opening an international trading account.